Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 244

1.

Psychopathology in methamphetamine-dependent adults 3 years after treatment.

Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson RA; Methamphetamine Treatment Project Corporate Authors..

Drug Alcohol Rev. 2010 Jan;29(1):12-20. doi: 10.1111/j.1465-3362.2009.00081.x.

2.

Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning.

Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R; Methamphetamine Treatment Project Corporate Authors..

Am J Addict. 2010 Sep-Oct;19(5):385-90. doi: 10.1111/j.1521-0391.2010.00061.x.

3.

Clinical course and outcomes of methamphetamine-dependent adults with psychosis.

Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R; Methamphetamine Treatment Project Corporate Authors..

J Subst Abuse Treat. 2008 Dec;35(4):445-50. doi: 10.1016/j.jsat.2007.12.004.

PMID:
18294802
4.

Primary and substance-induced psychotic disorders in methamphetamine users.

Hides L, Dawe S, McKetin R, Kavanagh DJ, Young RM, Teesson M, Saunders JB.

Psychiatry Res. 2015 Mar 30;226(1):91-6. doi: 10.1016/j.psychres.2014.11.077.

PMID:
25677394
5.

Psychiatric disorders in individuals with methamphetamine dependence: prevalence and risk factors.

Akindipe T, Wilson D, Stein DJ.

Metab Brain Dis. 2014 Jun;29(2):351-7. doi: 10.1007/s11011-014-9496-5.

PMID:
24532047
6.

Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up.

Glasner-Edwards S, Marinelli-Casey P, Hillhouse M, Ang A, Mooney LJ, Rawson R; Methamphetamine Treatment Project Corporate Authors..

J Nerv Ment Dis. 2009 Apr;197(4):225-31. doi: 10.1097/NMD.0b013e31819db6fe.

8.

Psychiatric comorbidity in methamphetamine dependence.

Salo R, Flower K, Kielstein A, Leamon MH, Nordahl TE, Galloway GP.

Psychiatry Res. 2011 Apr 30;186(2-3):356-61. doi: 10.1016/j.psychres.2010.09.014.

9.

The profile of psychiatric symptoms exacerbated by methamphetamine use.

McKetin R, Dawe S, Burns RA, Hides L, Kavanagh DJ, Teesson M, McD Young R, Voce A, Saunders JB.

Drug Alcohol Depend. 2016 Apr 1;161:104-9. doi: 10.1016/j.drugalcdep.2016.01.018.

PMID:
26874915
10.

A retrospective review of trends and clinical characteristics of methamphetamine-related acute psychiatric admissions in a South African context.

Vos PJ, Cloete KJ, le Roux A, Kidd M, Jordaan GP.

Afr J Psychiatry (Johannesbg). 2010 Nov;13(5):390-4.

11.

Neurocognitive deficits are associated with unemployment in chronic methamphetamine users.

Weber E, Blackstone K, Iudicello JE, Morgan EE, Grant I, Moore DJ, Woods SP; Translational Methamphetamine AIDS Research Center (TMARC) Group..

Drug Alcohol Depend. 2012 Sep 1;125(1-2):146-53.

12.

Neuropsychological function and delay discounting in methamphetamine-dependent individuals.

Hoffman WF, Moore M, Templin R, McFarland B, Hitzemann RJ, Mitchell SH.

Psychopharmacology (Berl). 2006 Oct;188(2):162-70.

PMID:
16915378
13.

Comorbid mental disorders in substance users from a single catchment area--a clinical study.

LangÄs AM, Malt UF, Opjordsmoen S.

BMC Psychiatry. 2011 Feb 12;11:25. doi: 10.1186/1471-244X-11-25.

14.
15.

Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program.

Kidorf M, Disney ER, King VL, Neufeld K, Beilenson PL, Brooner RK.

Drug Alcohol Depend. 2004 May 10;74(2):115-22.

PMID:
15099655
16.

Methamphetamine use by incarcerated women: comorbid mood and anxiety problems.

Vik PW.

Womens Health Issues. 2007 Jul-Aug;17(4):256-63.

PMID:
17544297
17.

Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence.

Iudicello JE, Woods SP, Vigil O, Scott JC, Cherner M, Heaton RK, Atkinson JH, Grant I; HIV Neurobehavioral Research Center (HNRC) Group..

J Clin Exp Neuropsychol. 2010 Aug;32(7):704-18. doi: 10.1080/13803390903512637.

18.

Personality disorders in substance abusers: relation to substance use.

Rounsaville BJ, Kranzler HR, Ball S, Tennen H, Poling J, Triffleman E.

J Nerv Ment Dis. 1998 Feb;186(2):87-95.

PMID:
9484308
20.

Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment.

Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R.

Eat Disord. 2011 May-Jun;19(3):259-69. doi: 10.1080/10640266.2011.566149.

Items per page

Supplemental Content

Support Center